← Back to Analyst Consensus 
AMPH Hold
Amphastar Pharmaceuticals, Inc.
Current Price —
Implied Upside —
Analysts 12
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 9, 2026 (14 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 18, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | — | 53% |
| Aug 7, 2026 | Piper Sandler | maintain | Neutral → Neutral | — | 54% |
| Aug 7, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Jun 29, 2026 | B of A Securities | downgrade | Neutral → Underperform | — | 53% |
| Jun 3, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | — | 53% |
| May 14, 2026 | Wells Fargo | downgrade | Overweight → Equal-Weight | — | 54% |
| May 11, 2026 | Piper Sandler | reiterate | Neutral → Neutral | — | 54% |
| May 8, 2026 | Needham | downgrade | Buy → Hold | — | 50% |
| Apr 21, 2026 | Jefferies | downgrade | Buy → Hold | — | 52% |
| Apr 8, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | — | 53% |
| Feb 27, 2026 | Wells Fargo | maintain | Overweight → Overweight | $30 | 54% |
| Feb 27, 2026 | Needham | maintain | Buy → Buy | $30 | 50% |
| Dec 9, 2025 | Barclays | initiate | — → Equal-Weight | $30 | 53% |
| Nov 7, 2025 | Needham | maintain | Buy → Buy | $34 | 50% |
| Oct 22, 2025 | Needham | reiterate | Buy → Buy | $36 | 50% |
| Aug 26, 2025 | B of A Securities | maintain | Neutral → Neutral | $32 | 53% |
| Aug 12, 2025 | Needham | upgrade | Hold → Buy | $36 | 50% |
| Aug 8, 2025 | Piper Sandler | maintain | Neutral → Neutral | $25 | 54% |
| May 12, 2025 | JP Morgan | downgrade | Overweight → Neutral | $30 | 54% |
| May 8, 2025 | Wells Fargo | maintain | Overweight → Overweight | $35 | 54% |
| Apr 10, 2025 | Needham | reiterate | Hold → Hold | $0 | 50% |
| Mar 21, 2025 | Piper Sandler | maintain | Neutral → Neutral | $32 | 54% |
| Feb 4, 2025 | Piper Sandler | downgrade | Overweight → Neutral | $36 | 54% |
| Nov 22, 2024 | Wells Fargo | initiate | — → Overweight | $55 | 54% |
| Aug 8, 2024 | Needham | reiterate | — → Hold | $0 | 50% |
| Aug 8, 2024 | Piper Sandler | maintain | Overweight → Overweight | $66 | 54% |
| Jun 27, 2024 | Piper Sandler | reiterate | Overweight → Overweight | $71 | 54% |
| May 22, 2024 | Needham | reiterate | — → Hold | $0 | 50% |
| May 9, 2024 | Needham | reiterate | — → Hold | $0 | 50% |
| Apr 10, 2024 | Needham | reiterate | — → Hold | $0 | 50% |
| Mar 5, 2024 | JP Morgan | initiate | — → Overweight | $60 | 54% |
| Nov 17, 2023 | B of A Securities | initiate | — → Neutral | $63 | 53% |
| May 17, 2023 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $44 | 54% |
| Oct 25, 2022 | Piper Sandler | maintain | — → Overweight | $40 | 54% |
| Jul 29, 2022 | Capital One | initiate | — → Overweight | $44 | 30% |
| Mar 15, 2022 | Wells Fargo | maintain | — → Equal-Weight | $32 | 54% |
| Mar 11, 2022 | Piper Sandler | maintain | — → Overweight | $35 | 54% |
| Jan 7, 2022 | Piper Sandler | upgrade | Neutral → Overweight | $28 | 54% |
| Mar 17, 2021 | Wells Fargo | maintain | — → Equal-Weight | $20 | 54% |
| Jan 8, 2021 | Wells Fargo | downgrade | Overweight → Equal-Weight | $21 | 54% |
| Oct 5, 2020 | Northland Capital Markets | upgrade | Market Perform → Outperform | $0 | 50% |
| Jul 9, 2020 | Northland Capital Markets | downgrade | Outperform → Market Perform | $23 | 50% |
| May 11, 2020 | BMO Capital | maintain | — → Market Perform | $21 | 53% |
| Mar 13, 2019 | Needham | downgrade | Buy → Hold | $0 | 50% |
| Mar 13, 2018 | BMO Capital | maintain | Market Perform → Market Perform | $19 | 53% |
| Nov 10, 2017 | BMO Capital | maintain | — → Market Perform | $17 | 53% |
| Nov 9, 2017 | Raymond James | downgrade | Outperform → Market Perform | $0 | 54% |
| Mar 14, 2017 | Raymond James | downgrade | Strong Buy → Outperform | $18 | 54% |
| Aug 9, 2016 | Jefferies | maintain | — → Buy | $19 | 52% |
| Jun 29, 2016 | BMO Capital | initiate | — → Market Perform | $0 | 53% |
Price Target Trend
Apr 13, 2026 Oct 26, 2026
EPS Estimates
+1y —
0q —
+1q —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days